CNBX Pharmaceuticals Inc (CNBX)
0.0098
0.00 (0.00%)
USD |
OTCM |
May 24, 16:00
CNBX Pharmaceuticals Enterprise Value: 1.560M for May 24, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 24, 2024 | 1.560M |
| May 23, 2024 | 1.588M |
| May 22, 2024 | 1.542M |
| May 21, 2024 | 1.542M |
| May 20, 2024 | 1.598M |
| May 17, 2024 | 1.604M |
| May 16, 2024 | 1.629M |
| May 15, 2024 | 1.582M |
| May 14, 2024 | 1.588M |
| May 13, 2024 | 1.552M |
| May 10, 2024 | 1.573M |
| May 09, 2024 | 1.567M |
| May 08, 2024 | 1.559M |
| May 07, 2024 | 1.577M |
| May 06, 2024 | 1.573M |
| May 03, 2024 | 1.610M |
| May 02, 2024 | 1.610M |
| May 01, 2024 | 1.598M |
| April 30, 2024 | 1.713M |
| April 29, 2024 | 1.574M |
| April 26, 2024 | 1.591M |
| April 25, 2024 | 1.660M |
| April 24, 2024 | 1.628M |
| April 23, 2024 | 1.640M |
| April 22, 2024 | 1.628M |
| Date | Value |
|---|---|
| April 19, 2024 | 1.610M |
| April 18, 2024 | 1.579M |
| April 17, 2024 | 1.637M |
| April 16, 2024 | 1.643M |
| April 15, 2024 | 1.619M |
| April 12, 2024 | 1.719M |
| April 11, 2024 | 1.629M |
| April 10, 2024 | 1.676M |
| April 09, 2024 | 1.607M |
| April 08, 2024 | 1.666M |
| April 05, 2024 | 1.598M |
| April 04, 2024 | 1.598M |
| April 03, 2024 | 1.716M |
| April 02, 2024 | 1.690M |
| April 01, 2024 | 1.750M |
| March 28, 2024 | 1.750M |
| March 27, 2024 | 1.691M |
| March 26, 2024 | 1.750M |
| March 25, 2024 | 1.694M |
| March 22, 2024 | 1.682M |
| March 21, 2024 | 1.682M |
| March 20, 2024 | 1.682M |
| March 19, 2024 | 1.683M |
| March 18, 2024 | 1.683M |
| March 15, 2024 | 1.722M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
1.457M
Minimum
Jul 03 2023
73.94M
Maximum
Feb 06 2020
17.70M
Average
15.15M
Median
Jan 27 2022
Enterprise Value Benchmarks
| NovaBay Pharmaceuticals Inc | 5.655M |
| Palatin Technologies Inc | 22.26M |
| iBio Inc | 27.27M |
| Theriva Biologics Inc | -10.02M |
| Oragenics Inc | 9.595M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.3255M |
| Revenue (Quarterly) | 0.0406M |
| Total Expenses (Quarterly) | 0.2471M |
| EPS Diluted (Quarterly) | -0.01 |
| Gross Profit Margin (Quarterly) | 84.69% |
| Profit Margin (Quarterly) | -800.9% |
| Earnings Yield | -575.2% |
| Normalized Earnings Yield | -386.60 |